This session examines disorders caused by abnormal immune activation against the body’s own tissues or by dysregulated innate inflammatory pathways. It covers disease mechanisms, genetic and environmental influences, clinical presentation, diagnosis, biomarkers, treatment response, disease monitoring, and the long-term impact of autoimmune and autoinflammatory conditions.
Researchers and clinicians may submit basic, clinical, translational, or population-based studies, along with case reports, reviews, and therapeutic evaluations. The session encourages participation from immunologists, rheumatologists, physicians, geneticists, laboratory researchers, pharmaceutical professionals, and multidisciplinary teams managing immune-mediated inflammatory diseases.
Title : Antibody proteases as translational biomarkers, targets, and biocatalysts of the next generation step as applicable for design driven precision medical practice
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign inspired and immunology related translational applications to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Targeting tumor-associated antigens through variable epitope libraries: Antitumor activity in breast cancer and acute myeloid leukemia
Braulio Alejandro Martinez Zarco, UNAM, Mexico
Title : Ultra-low-dose methotrexate combined with low-dose prednisolone in two distinct chronic disorders: A hypothesis-generating clinical comparison
Naylya Djumaeva, Research Institute of Virology, Uzbekistan
Title : Treatment outcomes of adult Filipino patients with drug susceptible pulmonary and extrapulmonary tuberculosis after anti-Koch’s rechallenge regimen
Jizelle Kay Cofulan Fang Asan, Baguio General Hospital and Medical Center, Philippines
Title : Clinical, immunological, and cytokine profiles of primary Sjögren’s syndrome in a Western Algerian population
Ouikhlef Narjesse, EHU Oran & Faculty of Medicine of Oran, Algeria